Nonetheless, a benefit of TZD-mediated treatment of T2DM is enhanced insulin responsiveness in skeletal muscle [11,12], the major site of insulin-dependent glucose uptake in peripheral tissues [13]. This evidence concerns the gene INS and type 2 diabetes mellitus.